U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07328373) titled 'Neurobiological and Genomic Predictors of Relapse in Depression' on Dec. 02, 2025.
Brief Summary: The goal of this observational study is to test whether the discontinuation of antidepressant medications for patients with depression can be decided after the normalization of biological parameters. The main questions it aims are:
1. When patients with depression treated with antidepressants, does their brain activity also become normal? If so,
2. Then, can we stop the antidepressant treatment and expect minimum repeat of depression?
The participants who receive a specific antidepressant treatment will be asked to:
* Undergo quanti...